Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+10.7%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $14.01M | -21.4% |
| 2024 | $17.82M | -12.3% |
| 2023 | $20.33M | +96.7% |
| 2022 | $10.33M | +111.8% |
| 2021 | $-87.64M | -56.2% |
| 2020 | $-56.10M | -1.9% |
| 2019 | $-55.03M | -62.7% |
| 2018 | $-33.82M | -55.0% |
| 2017 | $-21.82M | -28.8% |
| 2016 | $-16.95M | - |